Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 4:42 pm Purchase |
2024-02-02 | 13G | Sintx Technologies, Inc. SINT |
Lind Global Fund II LP | 4,325 9.900% |
3,038 (+235.92%) |
Filing History |
| 2024-02-06 5:28 pm Purchase |
2024-02-01 | 13G | Sidus Space, Inc. SIDU |
Lind Global Fund II LP | 222,200 8.300% |
222,200 (New Position) |
Filing History |
| 2024-02-06 5:26 pm Purchase |
2024-01-30 | 13G | Seelos Therapeutics, Inc. SEEL |
Lind Global Fund II LP | 11,022 9.900% |
11,022 (New Position) |
Filing History |
| 2024-01-18 4:28 pm Sale |
2023-12-31 | 13G | FingerMotion, Inc. FNGR |
Lind Global Fund II LP | 1,000 1.000% |
-3,214,296 (-99.97%) |
Filing History |
| 2024-01-04 4:31 pm Purchase |
2023-12-27 | 13G | Netcapital Inc. NCPL |
Lind Global Fund II LP | 20,286 9.900% |
20,286 (New Position) |
Filing History |
| 2024-01-04 4:30 pm Purchase |
2023-12-26 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Lind Global Fund II LP | 102,250 9.900% |
102,250 (New Position) |
Filing History |
| 2023-12-12 5:01 pm Purchase |
2023-12-12 | 13G | GSE Systems, Inc. GVP |
Lind Global Fund II LP | 272,189 9.900% |
272,189 (New Position) |
Filing History |
| 2023-12-07 4:30 pm Purchase |
2023-12-04 | 13G | TransCode Therapeutics, Inc. RNAZ |
Lind Global Fund II LP | 1,894 9.900% |
1,894 (New Position) |
Filing History |
| 2023-12-06 4:30 pm Purchase |
2023-12-05 | 13G | Polar Power, Inc. POLA |
Lind Global Fund II LP | 142,857 5.900% |
142,857 (New Position) |
Filing History |
| 2023-11-29 4:33 pm Purchase |
2023-11-22 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 450,000 9.900% |
450,000 (New Position) |
Filing History |
| 2023-11-09 4:32 pm Purchase |
2023-11-08 | 13G | Golden Minerals Company AUMN |
Lind Global Fund II LP | 1,360,000 9.900% |
1,360,000 (New Position) |
Filing History |
| 2023-10-20 4:58 pm Purchase |
2023-10-17 | 13G | Versus Systems Inc. VS |
Lind Global Fund II LP | 153,125 9.900% |
153,125 (New Position) |
Filing History |
| 2023-10-20 4:40 pm Purchase |
2023-10-17 | 13G | Versus Systems Inc. VS |
Lind Global Fund II LP | 153,125 9.900% |
153,125 (New Position) |
Filing History |
| 2023-10-10 4:31 pm Purchase |
2023-10-04 | 13G | Intelligent Bio Solutions Inc. INBS |
Lind Global Fund II LP | 32,167 9.900% |
19,792 (+159.93%) |
Filing History |
| 2023-09-28 4:30 pm Purchase |
2023-09-26 | 13D | ReWalk Robotics Ltd. LFWD |
Lind Global Fund II LP | 1,412,859 16.500% |
41,537 (+3.03%) |
Filing History |
| 2023-09-19 4:30 pm Purchase |
2023-09-11 | 13G | Blue Star Foods Corp. BSFC |
Lind Global Fund II LP | 8,500 9.900% |
8,500 (New Position) |
Filing History |
| 2023-09-15 4:30 pm Purchase |
2023-09-11 | 13G | Palisade Bio, Inc. PALI |
Lind Global Fund II LP | 49,554 7.900% |
47,488 (+2298.79%) |
Filing History |
| 2023-08-07 4:01 pm Purchase |
2023-07-28 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 385,000 9.900% |
385,000 (New Position) |
Filing History |
| 2023-07-31 7:50 pm Purchase |
2023-07-20 | 13G | Talphera, Inc. TLPH |
Lind Global Fund II LP | 1,102,944 6.500% |
1,102,944 (New Position) |
Filing History |
| 2023-07-03 4:00 pm Purchase |
2023-06-27 | 13G | SMX (Security Matters) Public Limited Company SMX |
Lind Global Fund II LP | 68 9.900% |
68 (New Position) |
Filing History |